Evidence map›Paper›PMID 31312859›Full record

ArticleJournal of molecular medicine (Berlin, Germany)2019

The orphan nuclear receptor NUR77 promotes trophoblast invasion at early pregnancy through paracrine placental growth factor.

Xiao-Cui Li, Xiang-Jie Yin, Wei Hong, Jie Liu, Feng Jin, Bei-Ying Wang, Yu-Mei Wang, Fu-Ju Tian

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular medicine (Berlin, Germany), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Controversy and multiple roles of the solitary nucleus receptor Nur77 in disease and physiology.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Xiao-Cui LiDepartment of Gynecology and Obstetrics, Shanghai First Maternity and Infant Hospital, TongJi University School of Medicine, Shanghai, 201204, People's Republic of China.
Xiang-Jie YinDepartment of Gynecology and Obstetrics, Shanghai First Maternity and Infant Hospital, TongJi University School of Medicine, Shanghai, 201204, People's Republic of China.
Wei HongDepartment of Gynecology and Obstetrics, Shanghai First Maternity and Infant Hospital, TongJi University School of Medicine, Shanghai, 201204, People's Republic of China.
Jie LiuReproductive Medicine, Qingdao Municipal Hospital, Qingdao, 266071, Shandong, People's Republic of China.
Feng JinDepartment of Obstetrics and Gynecology, the Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, 200233, People's Republic of China.
Bei-Ying WangDepartment of Gynecology and Obstetrics, Shanghai First Maternity and Infant Hospital, TongJi University School of Medicine, Shanghai, 201204, People's Republic of China.
Yu-Mei WangDepartment of Gynecology and Obstetrics, Shanghai First Maternity and Infant Hospital, TongJi University School of Medicine, Shanghai, 201204, People's Republic of China.
Fu-Ju TianInternational Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200030, People's Republic of China. fjtian@sibs.ac.cn.ORCID 0000-0002-3638-8620
Shanghai First Maternity and Infant Hospital · CNQingdao University · CNShanghai Jiao Tong University · CNShanghai Sixth People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

NR4A1 (NUR77) is an orphan nuclear receptor that has been implicated in both cell survival and apoptosis. However, the role of NUR77 in trophoblast function during early placenta development has not been fully elucidated. In this study, we showed that NUR77 expression was significantly lower in the villi of the recurrent miscarriage (RM) group compared to that in the healthy controls (HCs) group. We used immunohistochemistry and found that NUR77 was highly expressed in human placental villi during early pregnancy, especially in syncytiotrophoblast (STB), and was expressed at a much lower level in STB from the RM group than in those from HC group. Western blotting data further confirmed that NUR77 was highly expressed in primary human term placental STB and the FSK-induced BeWo cell line. Moreover, antibody array screening and ELISA revealed that NUR77 promoted significant placental growth factor (PGF) expression during trophoblast fusion. Ectopic overexpression and knockdown experiments demonstrated that PGF was a novel downstream target of NUR77, and serum PGF expression correlated positively with trophoblast NUR77 mRNA levels in HCs and RM patients. Importantly, bioinformatics analysis identified two NUR77 binding sites in the PGF promoter region, and chromatin immunoprecipitation (ChIP) coupled with Western blotting analysis further verified that NUR77 bound directly to the PGF promoter region and promoted PGF expression. Furthermore, in a BeWo/HTR-8 co-culture system, FSK-induced BeWo-secreted PGF promoted HTR-8 cell migration and invasion, and an anti-PGF antibody reversed this effect. Collectively, these results indicated that NUR77 may play a key role in regulating trophoblast invasion at early pregnancy. KEY MESSAGES: NUR77 expression was significantly decreased in the syncytiotrophoblast of the recurrent miscarriage group compared to that in the healthy control group. NUR77 promoted PGF expression during trophoblast fusion. ChIP and western blotting experiments verified that NUR77 bound directly to the PGF promoter region and activated PGF expression in trophoblast. Trophoblast-derived PGF promoted HTR-8 cell migration and invasion in a cell co-culture system.

Indexed as

AdultBinding SitesCell LineCell MovementFemaleHumansNuclear ProteinsNuclear Receptor Subfamily 4, Group A, Member 1PlacentaPlacenta Growth FactorPregnancyPregnancy ProteinsPromoter Regions, GeneticRNA, MessengerTranscription FactorsTrophoblastsNR4A1 protein, humanNuclear ProteinsNuclear Receptor Subfamily 4, Group A, Member 1PGF protein, humanPlacenta Growth FactorPregnancy ProteinsRNA, MessengerTranscription Factorstrophoblast-derived growth factorEarly pregnancyNUR77PGFSyncytiotrophoblastTrophoblast invasion

Identifiers

PMID31312859
OpenAlexW2960469966

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.